Leadership Team

Rao Bezwada

Rao Bezwada, PhD, FRSC

CEO & Founder

Neeti Srivastava, PhD

Neeti Srivastava, PhD

Director, R&D, Business
Development and Quality

Sujata Moton, MBA

Sujata Moton, MBA

Chief Financial Officer

Rao Bezwada

Rao Bezwada, PhD, FRSC
CEO & Founder

An accomplished scientist and entrepreneur, Dr. Bezwada established Bezwada Biomedical, an innovation-based and technology-driven research company. The company is focused on developing a wide range of novel absorbable polymeric biomaterials capable of enhancing quality of life by producing next generation biodegradable medical devices. Dr. Bezwada is the inventor of numerous absorbable technologies including absorbable polyurethanes, amino acid polymers, polyester amides, and polyoxaesters.

Dr. Bezwada earned a doctorate in chemistry from the Stevens Institute of Technology in New Jersey and has been regarded as a leading expert in the field of bioabsorbable polymers for medical devices. He has over 40 years of research experience in the medical device industry, including 20 years of service at Ethicon, Inc. (a Johnson & Johnson Company) prior to establishing Bezwada Biomedical in 2003.

Dr. Bezwada’s commitment toward medical research is attested to by his original research contributions with critical applications in health care. While at Ethicon, his research and development efforts led to the launch of a number of products including Monocryl®, a new ultra pliable synthetic absorbable monofilament suture. This product has represented worldwide sales of more than two billion dollars since its launch in 1993 and current annual sales of over 100 million dollars. In recognition of this invention and new product development, Johnson & Johnson, Inc. awarded Dr. Bezwada the prestigious Johnson Medal in 1996. In 2020, Dr. Bezwada was awarded an NSF Phase 1 SBIR grant to develop novel absorbable polyurethane tissue adhesives and in 2023 an NSF Phase 2 SBIR grant to further product development and commercialization.

Dr. Bezwada has been a prolific inventor and has been <strong>issued more than 135 U.S. patents.</strong> Part of his patent portfolio covering absorbable polyurethane technology platform has been licensed by Abyrx Inc. towards developing products for wound healing and bone applications. His absorbable polyurethane technology has been used in Montage®, a bone hemostat which was approved by US FDA and commercialized by Abyrx. Dr. Bezwada has authored several scholarly articles and has been published in international scientific journals, along with numerous presentations at both national and international meetings including the American Chemical Society and the Society for Biomaterials.

In addition to his passion for science and technical accomplishments, Dr. Bezwada also possesses a deep commitment for paying it forward and has established a non-profit organization named the Society for Basic Needs in India. This organization has a mission aimed at improving the quality of life for those less fortunate by providing them with essential amenities and opportunities for health and education.

Neeti Srivastava, PhD

Neeti Srivastava, PhD
Director, R&D, Business
Development and Quality

Dr. Srivastava oversees all the activities related to R&D, business development and quality affairs of Bezwada Biomedical. Dr. Srivastava joined Bezwada Biomedical in 2009 after completing her Ph.D. in Biochemistry. Since joining Bezwada Biomedical, Dr. Srivastava has held roles of increasing responsibilities. Dr. Srivastava has 10 years of experience in development of absorbable polymers and has been responsible for the supervision of all the polymer synthesis and characterization work. She helped develop the absorbable polyurethane formulation that received 510K approval from the FDA and was commercialized as a bone hemostat by Abyrx, Inc. under the trade name Montage. In 2014, she led the quality efforts resulting in ISO 9001 certification of Bezwada Biomedical. Furthermore, Dr. Srivastava has authored several scholarly articles and has been published in international scientific journals, along with presentations at American Chemical Society and Society for Biomaterials conferences.
Sujata Moton, MBA

Sujata Moton, MBA
Chief Financial Officer

Ms. Sujata Moton oversees all financial matters at Bezwada Biomedical including accounting, budgeting, and taxation functions and has all human resources responsibilities.
Ms. Moton holds a Bachelor’s degree in accounting and an MBA in finance, both from Rutgers University. Her experience also includes management and accounting positions with Johnson & Johnson.

An accomplished scientist and entrepreneur, Dr. Bezwada established Bezwada Biomedical, an innovation-based and technology-driven research company. The company is focused on developing a wide range of novel absorbable polymeric biomaterials capable of enhancing quality of life by producing next generation biodegradable medical devices. Dr. Bezwada is the inventor of numerous absorbable technologies including absorbable polyurethanes, amino acid polymers, polyester amides, and polyoxaesters.

Dr. Bezwada earned a doctorate in chemistry from the Stevens Institute of Technology in New Jersey and has been regarded as a leading expert in the field of bioabsorbable polymers for medical devices. He has over 40 years of research experience in the medical device industry, including 20 years of service at Ethicon, Inc. (a Johnson & Johnson Company) prior to establishing Bezwada Biomedical in 2003.

Dr. Bezwada’s commitment toward medical research is attested to by his original research contributions with critical applications in health care. While at Ethicon, his research and development efforts led to the launch of a number of products including Monocryl®, a new ultra pliable synthetic absorbable monofilament suture. This product has represented worldwide sales of more than two billion dollars since its launch in 1993 and current annual sales of over 100 million dollars. In recognition of this invention and new product development, Johnson & Johnson, Inc. awarded Dr. Bezwada the prestigious Johnson Medal in 1996. In 2020, Dr. Bezwada was awarded an NSF Phase 1 SBIR grant to develop novel absorbable polyurethane tissue adhesives and in 2023 an NSF Phase 2 SBIR grant to further product development and commercialization.

Dr. Bezwada has been a prolific inventor and has been issued more than 135 U.S. patents. Part of his patent portfolio covering absorbable polyurethane technology platform has been licensed by Abyrx Inc. towards developing products for wound healing and bone applications. His absorbable polyurethane technology has been used in Montage®, a bone hemostat which was approved by US FDA and commercialized by Abyrx. Dr. Bezwada has authored several scholarly articles and has been published in international scientific journals, along with numerous presentations at both national and international meetings including the American Chemical Society and the Society for Biomaterials.

In addition to his passion for science and technical accomplishments, Dr. Bezwada also possesses a deep commitment for paying it forward and has established a non-profit organization named the Society for Basic Needs in India. This organization has a mission aimed at improving the quality of life for those less fortunate by providing them with essential amenities and opportunities for health and education.

Dr. Srivastava oversees all the activities related to R&D, business development and quality affairs of Bezwada Biomedical. Dr. Srivastava joined Bezwada Biomedical in 2009 after completing her Ph.D. in Biochemistry. Since joining Bezwada Biomedical, Dr. Srivastava has held roles of increasing responsibilities. Dr. Srivastava has 10 years of experience in development of absorbable polymers and has been responsible for the supervision of all the polymer synthesis and characterization work. She helped develop the absorbable polyurethane formulation that received 510K approval from the FDA and was commercialized as a bone hemostat by Abyrx, Inc. under the trade name Montage. In 2014, she led the quality efforts resulting in ISO 9001 certification of Bezwada Biomedical. Furthermore, Dr. Srivastava has authored several scholarly articles and has been published in international scientific journals, along with presentations at American Chemical Society and Society for Biomaterials conferences.

Ms. Sujata Moton oversees all financial matters at Bezwada Biomedical including accounting, budgeting, and taxation functions and has all human resources responsibilities.
Ms. Moton holds a Bachelor’s degree in accounting and an MBA in finance, both from Rutgers University. Her experience also includes management and accounting positions with Johnson & Johnson.

Ms. Sujata Moton oversees all financial matters at Bezwada Biomedical including accounting, budgeting, and taxation functions and has all human resources responsibilities.
Ms. Moton holds a Bachelor’s degree in accounting and an MBA in finance, both from Rutgers University. Her experience also includes management and accounting positions with Johnson & Johnson.

Discuss your degradable polymer application with Dr. Neeti Srivastava.

These video calls are only for potential customer applications. Please, no solicitations or spam. For general inquiries or other questions, feel free to fill out the contact us form.

Polymers

Applications

How We Work

Absorbable Biomaterials Innovators

 

ISO 13485 CertifiedISO 13485 CertifiedBezwada Award Badge

908.281.7529

15 Ilene Ct
Suite 1
Hillsborough Township, NJ 08844

info@bezwadabiomedical.com

Get in Touch